Farms.com Home   News

U.S. agribusiness booms with over $174 Billion in global exports

By Farms.com

The U.S. agriculture sector celebrated a groundbreaking year in 2023, with exports soaring to $174.9 billion. This achievement highlights the sector's resilience and the effective strategies implemented by the USDA and the Administration to ensure American agriculture's robust presence in global markets.

Among the year's highlights were strategic trade wins, such as entering the Vietnamese market for grapefruit, enhancing ethanol exports to Japan, and the removal of various retaliatory tariffs by India. These accomplishments have opened doors to markets valued at approximately $6.4 billion, offering new opportunities for U.S. agricultural producers.

Efforts by the U.S. Codex Office ensured the establishment of new pesticide residue limits, safeguarding U.S. agricultural interests in the global marketplace. Additionally, the USDA facilitated numerous trade missions and participated in international trade shows, connecting U.S. businesses with international buyers and leading to significant sales projections.

The inauguration of the Regional Agricultural Promotion Program (RAPP) signifies a forward-looking approach to market development, focusing on emerging markets with high growth potential. This initiative is expected to enhance U.S. agricultural exports by diversifying into new markets and increasing market shares.

The USDA's commitment to global food security remained steadfast, with significant investments made through its Food for Progress and McGovern-Dole programs, benefiting dozens of countries.

Reflecting on the successes of 2023, the USDA sets its sights higher for 2024, aiming to further diversify export markets and solidify the global standing of U.S. agricultural products. This ongoing commitment underscores the importance of trade and exports in strengthening American agriculture and supporting economic growth.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.